Skip to main content
MiMedx Group, Inc. (MDXG)
NASDAQ: MDXG · Real-Time Price · USD
3.400
+0.060 (1.80%)
At close: Apr 28, 2026, 4:00 PM EDT
3.340
-0.060 (-1.76%)
Pre-market: Apr 29, 2026, 7:07 AM EDT

MiMedx Group Revenue

In the year 2025, MiMedx Group had annual revenue of $418.63M with 19.99% growth. MiMedx Group had revenue of $118.10M in the quarter ending December 31, 2025, with 27.11% growth.

Revenue (ttm)
$418.63M
Revenue Growth
+19.99%
P/S Ratio
1.21
Revenue / Employee
$518,106
Employees
808
Market Cap
505.13M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025418.63M69.75M19.99%
Dec 31, 2024348.88M27.40M8.52%
Dec 31, 2023321.48M53.64M20.03%
Dec 31, 2022267.84M25.82M10.67%
Dec 31, 2021242.02M-6.22M-2.50%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Valneva SE 205.07M
4D Molecular Therapeutics 85.21M
ADC Therapeutics 81.36M
Fulcrum Therapeutics 80.00M
XOMA Royalty 52.15M
Verastem 30.91M
Upstream Bio 2.85M
Lyell Immunopharma 36.00K
Revenue Rankings

MDXG News

More News